Accro Bioscience Inc. raised $50M in Series C funding led by OrbiMed to accelerate the Phase IIb clinical trial of AC-101 for Ulcerative Colitis.
Amount Raised
$50 Million
Round Type
Series C
SuzhouCommerce and ShoppingFood and BeverageHealth CareInvestors
Description
Accro Bioscience Inc., based in Suzhou, China, raised $50M in Series C funding. The round was led by OrbiMed, with participation from several investors. The company aims to utilize the funds to advance its clinical trial for AC-101. This is part of their effort to develop treatments for inflammatory and autoimmune diseases.
Quick answer
Accro Bioscience raised $50 Million in a Series C round, dated May 19, 2026. Investors: Orbimed, Tcg Crossover, Lav, Cenova Capital, Shenzhen Capital Group and Oriza Holdings. Accro Bioscience is based in Suzhou, Jiangsu, China.
- How much did Accro Bioscience raise?
- Accro Bioscience raised $50 Million in a Series C round on May 19, 2026.
- Who invested in Accro Bioscience?
- Orbimed, Tcg Crossover, Lav, Cenova Capital, Shenzhen Capital Group and Oriza Holdings are named as investors in this round.
- What does Accro Bioscience do?
- Accro Bioscience was established in late 2017 and raised exclusive series A investment from Morningside Ventures.
- Where is Accro Bioscience based and how big is it?
- Accro Bioscience is based in Suzhou, Jiangsu, China.
Source: Fundz verified event record.
Who else raised in Commerce and Shopping and Food and Beverage around the same time
Companies in the same sectors as Accro Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Myota raised $4.5M (Seed) on July 2, 2026.
- The Func. Lab raised $1.5M (Seed) on June 29, 2026.
- Nature’s Miracle Holding raised $566K (Series A) on June 1, 2026.
- The Sweet Change raised $72K (Seed) on May 18, 2026.
- Gestala Technology raised $66M (Angel) on July 3, 2026.
- Ivory raised $1M (Seed) on July 3, 2026.
Who to call at Accro Bioscience, and when
A new round usually means Accro Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Accro Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Accro Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Accro Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Accro Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Accro Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.